Venture Capital

As AI tools multiply, Cloudhands emerges with a unified platform and veteran leadership, promising to end the chaos of juggling multiple models.

Dr. Lu Xianping, crowned EY Entrepreneur Of The Year, didn't just invent new drugs; he helped reinvent China's entire pharmaceutical industry.

With industry veteran Don Cantow at the helm, Altium aims to unify electronics design on an open platform, accelerating its post-Renesas acquisition strategy.

At CES 2026, Seyond debuts its Hummingbird solid-state LiDAR with a major OEM win, challenging rivals in a race to define the future of autonomy.

A US-based Sikh group proposes a Christian homeland in India, citing a wave of anti-Christian violence that marred Christmas 2025 celebrations.

With a major funding round, Biobeat aims to replace bulky cuffs with a discreet patch, potentially revolutionizing hypertension care for millions.

Esports giant OverActive Media is raising fresh capital. Is this a strategic push into AI and esports dominance or a necessary move to shore up its finances?

Privately held MMMera hires strategic firm CND-SA to scale its Guillotine® gaming IP, a move highlighting the high-stakes game of professionalizing art.

A $300,000 financing will fuel Lomiko's push to develop battery-grade graphite in Quebec and explore a strategic antimony-gold prospect in Newfoundland.

MENA's streaming leader Anghami doubles its subscribers after its OSN+ merger, but a $37M loss raises questions about its high-stakes growth strategy.

The investment firm renews its plan to repurchase up to 5% of its units, signaling a strong belief that its market price is below its intrinsic value.

Amidst legal industry fears of generative AI, BriefCatch's $6M funding and stellar retention prove the value of a trusted, specialized AI writing partner.

Berlin-based Sportstech suspends acquisition talks with Nasdaq's TRNR, derailing U.S. plans and sparking a public dispute over the failed deal.

Gaming giant Meridianbet extends its title sponsorship with EuroLeague's Crvena Zvezda, signaling a major strategic play in European basketball.

Transit-tech firm Argo gets a $1.4M boost from TheVentureCity, a fund led by a former Facebook colleague of Argo's CEO, to scale its smart city solutions.

Veracyte prepares for the J.P. Morgan conference, where it will showcase its AI and genomic strategy amid strong financials and a competitive market.

The popular brunch chain is betting on a digital marketing guru to transform its customer experience and accelerate growth in a tech-driven market.

WISeKey's satellite arm, WISeSat, is merging with a SPAC to build a quantum-resilient IoT network, a key step in securing future global communications.

With soaring revenue and a landmark FDA approval for its Shield cancer test, Guardant Health's upcoming JPM presentation is poised to define its future.

The semiconductor equipment firm will release crucial 2025 and 2026 financial guidance in January, offering a key early test of the industry's momentum.